Celyad Oncology S.A.

CLYYFOTCHealthcare● Active

$0.25

+$0.00(+0.00%)

Market Cap$11190476

P/E Ratio—

52W High$0.53

52W Low$0.15

Avg Volume127

Open$0.32

Beta1.20

Overview

Celyad Oncology S.A. (CLYYF) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CLYYF · as of Mar 23, 2023

Latest filing snapshot

-60-68.18%vs prior year

Celyad Oncology S.A. (CLYYF) employee data is sourced from the annual SEC 20-F filing. As of 2022, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2022-12-31·Full-time · Global

Total Employees

Change (1Y)

-60

Growth % (1Y)

-68.18%

Revenue / Employee

$750

Net Income / Employee

$29.6K

Market Cap

$11M

CLYYF Employee Count

2015 – 2022 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2023-03-23	2022-12-31	28	-60	-68.18%
2022-03-24	2021-12-31	88	-4	-4.35%
2021-03-24	2020-12-31	92	-9	-8.91%
2020-03-25	2019-12-31	101	+11	+12.22%
2019-04-05	2018-12-31	90	+20	+28.57%
2018-04-06	2017-12-31	70	-8	-10.26%
2017-04-04	2016-12-31	78	-4	-4.88%
2016-04-08	2015-12-31	82	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Celyad Oncology S.A.YOU

Blue Water Vaccines, Inc.

12$3M #5

ALLR

Allarity Therapeutics, Inc.

6$25M

CHNXF

ChitogenX Inc.

5$1M

CLAZF

Claritas Pharmaceuticals, Inc.

3$0M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CLYYF peer comparison

About CLYYF employees

CLYYF Employees · Headcount

Celyad Oncology S.A. (CLYYF) employee data is sourced from the annual SEC 20-F filing. As of 2022, Celyad Oncology S.A. had 28 full-time employees globally. Full-time employees only. Global consolidated headcount.

Celyad Oncology S.A. employs 28 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $750, reflecting the company's operational efficiency.

Celyad Oncology S.A.'s workforce decreased by 60 (68.18%) in 2022 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Celyad Oncology S.A.'s revenue per employee of $750 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CLYYF Employees · 5 questions

As of the latest SEC 20-F filing (2022), Celyad Oncology S.A. had 28 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Celyad Oncology S.A. employee counthow many employees does Celyad Oncology S.A. haveCLYYF total employees 2022

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2023-03-23